Establishment Labs Holdings Inc represents a strong set of values and corporate philosophy. The company is dedicated to providing innovative medical technology solutions with a focus on safety and aesthetic outcomes. Their commitment to patient satisfaction is evident in their portfolio of breast and body aesthetic products. Establishment Labs Holdings Inc prioritizes quality, striving to meet rigorous standards and gaining regulatory approvals. With a customer-centric approach, the company aims to deliver state-of-the-art, personalized solutions that elevate patient experiences. By continuously investing in research and development, Establishment Labs Holdings Inc remains at the forefront of the industry, delivering excellence and transforming lives.

Establishment Labs Holdings Inc is primarily present in various countries and regions across the globe. The company has a strong presence in the United States, where it is headquartered. Additionally, Establishment Labs Holdings Inc has significant operations in Europe, with a focus on countries like France, Germany, Spain, Italy, and the United Kingdom. The company also has a presence in Latin America, particularly in Brazil, Colombia, Mexico, and Argentina. With its expanding international reach, Establishment Labs Holdings Inc continues to establish its footprint in the global market, driving growth and innovation in the field of medical aesthetics.

Establishment Labs Holdings Inc has achieved significant milestones since its establishment. Some notable achievements include receiving FDA approval for the Motiva Implants® line, which offers cutting-edge technology for breast augmentation and reconstruction. The company has expanded its global presence by securing regulatory approvals in various countries, further enhancing its market reach. Establishment Labs Holdings Inc has also fostered collaborations with renowned plastic surgeons and academic institutions to continually advance its innovative medical solutions. These achievements highlight the company's commitment to revolutionizing the aesthetics industry and improving patient outcomes.

Establishment Labs Holdings Inc is a renowned global medical device company that specializes in breast aesthetics and reconstruction technologies. Founded in 2004, the company has established itself as a leading player in the field, offering innovative products and solutions that cater to the specific needs of patients and healthcare professionals. With a focus on safety, aesthetics, and patient satisfaction, Establishment Labs has earned a strong reputation worldwide. As a publicly traded company, it operates with a commitment to excellence, continually advancing its technologies and expanding its global footprint. With its dedication to quality and innovation, Establishment Labs Holdings Inc continues to make significant contributions to the medical aesthetics industry.

The main competitors of Establishment Labs Holdings Inc in the market include other leading companies in the medical aesthetics industry, such as Allergan Plc, Sientra Inc, and Johnson & Johnson. These companies also offer a range of aesthetic products and solutions, and compete with Establishment Labs in terms of product innovation, market share, and customer base.

Establishment Labs Holdings Inc is primarily active in the aesthetic and medical device industries.

The business model of Establishment Labs Holdings Inc is focused on designing, manufacturing, and marketing medical devices and breast implants for aesthetic and reconstructive surgeries. The company specializes in the Motiva Implant Matrix, a highly innovative and advanced silicone breast implant technology. Establishment Labs aims to provide safe, high-quality, and aesthetically pleasing solutions to meet the evolving needs of surgeons and patients globally. Through continuous research and development, they strive to expand their product portfolio and enhance patient outcomes. With a strong emphasis on innovation and customer satisfaction, Establishment Labs is committed to delivering excellence in the field of aesthetic and reconstructive surgery.

สัดส่วนราคาต่อกำไรของ Establishment Labs Holdings คือ -16.72

KUV ของ Establishment Labs Holdings คือ 6.9

AlleAktien คุณภาพสกอร์สำหรับ Establishment Labs Holdings คือ 3/10.

คาดหวัง Establishment Labs Holdings มียอดขายอยู่ที่ 169.8 ล้าน USD

กำไร คาดหวัง Establishment Labs Holdings คือ -70.06 ล้าน USD

Establishment Labs Holdings Inc is a leading company in the medical aesthetics industry. The company's business model is based on the manufacturing and distribution of breast implants, as well as the provision of complementary plastic surgery products and technologies. One of the focuses of Establishment Labs Holdings is the manufacturing of round, anatomically shaped, and textured silicone gel breast implants. These products are sold under the brand Motiva and offer a wide range of sizes and shapes to meet individual patient needs and preferences. Motiva implants are known for their high quality, durability, and safety, and are available in over 70 countries worldwide. In addition to breast implants, Establishment Labs Holdings offers a range of complementary products, including the MatrixChamber mattress overlay manufactured in Full HD technology. This technology is also used in a variety of surgical instruments distributed by the company. The technological advancements achieved by Establishment Labs Holdings can be attributed to its innovative and dedicated team of researchers and developers. The company heavily invests in research and development to create new technologies and products that benefit both patients and physicians. Another important aspect of Establishment Labs Holdings' business model is its collaboration with a network of certified plastic surgeons in various countries. The company offers training and educational opportunities for surgeons interested in using Motiva implants and other products from Establishment Labs Holdings. This ensures that its products are being used by qualified professionals and also provides a high level of customer service and support for patients. In addition to offering medical products and technologies, Establishment Labs Holdings is committed to social responsibility. The company is dedicated to sustainability and environmental friendliness and is certified as carbon-neutral and for sustainable value creation. In summary, the business model of Establishment Labs Holdings Inc is focused on providing high-quality medical products and technologies to plastic surgeons and patients worldwide. Through its focused research and development efforts, collaboration with qualified professionals, and commitment to sustainability, the company is well positioned to meet the constantly evolving needs and demands of the medical aesthetics industry.

Establishment Labs Holdings จ่ายเงินปันผล 0 USD ผ่าน ครั้งในหนภายในหนึ่งปี.

ปัจจุบันไม่สามารถคำนวณเงินปันผลสำหรับ Establishment Labs Holdings หรือบริษัทไม่จ่ายเงินปันผล.

ISIN ของ Establishment Labs Holdings คือ VGG312491084

WKN ของ Establishment Labs Holdings คือ A2JRE4.

ตัวย่อของ Establishment Labs Holdings คือ ESTA

ภายในช่วง 12 เดือนที่ผ่านมา Establishment Labs Holdings จ่ายเงินปันผลทั้งหมด นี้เทียบเท่ากับอัตราผลตอบแทนจากเงินปันผลประมาณ สำหรับ 12 เดือนข้างหน้า Establishment Labs Holdings คาดว่าจะจ่ายเงินปันผลทั้งหมด 0 USD

อัตราผลตอบแทนเงินปันผลของ Establishment Labs Holdings ในปัจจุบันคือ

Establishment Labs Holdings จ่ายเงินปันผลทุกไตรมาส การจ่ายเงินปันผลจะเกิดขึ้นในเดือน

Establishment Labs Holdings จ่ายเงินปันผลทุกปีในช่วง 0 ปีที่ผ่านมา.

คาดว่าในช่วง 12 เดือนข้างหน้าจะมีการจ่ายเงินปันผลทั้งหมด 0 USD ซึ่งเทียบเท่ากับผลตอบแทนจากเงินปันผลร้อยละ 0 %

Establishment Labs Holdings ถูกจัดให้อยู่ในภาคส่วน 'สุขภาพ'

เพื่อรับเงินปันผลล่าสุดของ Establishment Labs Holdings ในวันที่ 4/12/2567 ที่มูลค่า 0 USD คุณจะต้องถือหุ้นไว้ในพอร์ตก่อนวันที่เป็น Ex-Tag ในวันที่ 4/12/2567

การจ่ายเงินปันผลครั้งล่าสุดเกิดขึ้นเมื่อวันที่ 4/12/2567

ในปี 2023 บริษัท Establishment Labs Holdings ได้จ่ายเงินปันผลเป็นจำนวน 0 USD

เงินปันผลของ Establishment Labs Holdings จะถูกจ่ายใน USD